Vincent J. Angotti
2022
In 2022, Vincent J. Angotti earned a total compensation of $1.3M as Chief Executive Officer at AcelRx Pharmaceuticals, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $257,799 |
|---|---|
| Option Awards | $233,892 |
| Salary | $636,540 |
| Stock Awards | $156,585 |
| Other | $12,200 |
| Total | $1,297,016 |
Angotti received $636.5K in salary, accounting for 49% of the total pay in 2022.
Angotti also received $257.8K in non-equity incentive plan, $233.9K in option awards, $156.6K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Vincent J. Angotti's compensation ranked 2,530th out of 5,756 executives tracked by ExecPay. In other words, Angotti earned more than 56.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,530 out of 5,756 | 56th |
Division Manufacturing | 1,394 out of 3,133 | 56th |
Major group Chemicals And Allied Products | 632 out of 1,419 | 56th |
Industry group Drugs | 586 out of 1,320 | 56th |
Industry Pharmaceutical Preparations | 420 out of 966 | 57th |
Source: SEC filing on August 28, 2023.
Angotti's colleagues
We found two more compensation records of executives who worked with Vincent J. Angotti at AcelRx Pharmaceuticals in 2022.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019